Peptides 2018 is to be held on 10th December,2018

10-11 December 2018 ∣ Amsterdam, Netherlands

Website:https://biotechpharmasummit.com/index.php/event/peptides-2018/

 

About Conference:

On 10 & 11 December 2018, Amsterdam (Netherlands) will host the BioTech Pharma Summit: Peptides 2018 conference. This year’s event will bring together key decision makers and innovators within this rapidly growing field. This intensive 2-Day program will examine various peptide discovery and synthesis techniques and synthesized and modified peptides

Why to Attend?

The BioTech Pharma Summit: Peptides 2018 will explore the burgeoning world of Peptide Therapeutics and how peptides are being engineered to penetrate cancer tumors and conquer unmet medical needs. Improving peptide properties, such as stability and half-life, will also be discussed, along with innovating routes of administration.

Target Audience:

• Peptides Research
• Biologics Research
• Peptide Synthesis
• Discovery Chemistry
• Peptide Characterisation
• Therapeutic Discovery
• Biotherapeutics Research
• Structural Biology
• Peptide Discovery
• Peptidomimetics
• New Modalities
• Peptide Delivery
• Medicinal Chemistry
• Peptide Therapeutics
• Biologics Development
• Peptide Engineering
• Peptide Chemistry
• Molecular Biology
• Peptide Development
• NBE Discovery
• Peptide Screening
• Technology Innovation
• Peptide Formulation

 

Conference Highlights:

• Advances in peptide synthesis technologies, strategies, novel methods
• New methods for peptide purification and characterisation
• Improving peptide properties: stability, bioavailability, half-life extension
• Platforms for the discovery & development of peptides
• New Cyclic Peptide Formats
• Macrocyclic peptides and their applications in drug discovery
• New peptides for novel disease treatments: case studies
• Computer-aided peptide drug design
• Peptides Therapeutics: Updates from preclinical and clinical development
• Peptide Manufacturing, Formulation & Delivery
• Understanding the Mechanism of Physical Instability of Peptide Pharmaceuticals
• Use of Cell Penetrating Peptides to Mute Physiologically Deleterious Signal Cascades
• Generation of Long-Acting Biotherapeutics
• Development of Bicyclic Peptides for Therapeutic Application
• Patient-Focused Peptide Delivery
• Lipid Conjugates for Peptide Drug Delivery

 

Contact us

 

Diogo Lino Ribeiro

Tel: +351 915 239 640

Email: diogo.ribeiro@epmgroup.org